BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND LDH AND Clinical Outcome
8 results:

  • 1. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
    Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
    J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.
    Silvestris N; Scartozzi M; Graziano G; Santini D; Lorusso V; Maiello E; Barni S; Cinieri S; Loupakis F; Pisconti S; Brunetti AE; Palasciano G; Palmieri VO; Del Prete M; Dell'Aquila E; Latiano TP; Petrelli F; Lutrino S; Rossini D; Giampieri R; Lotesoriere C; Cascinu S
    Expert Opin Biol Ther; 2015 Feb; 15(2):155-62. PubMed ID: 25411089
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis.
    Li XP; Wen F; Yang W; Deng YB; Li M; Zhang PF; Tang RL; Li Q; Wei YQ
    Tumori; 2014; 100(4):446-51. PubMed ID: 25296595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
    Scartozzi M; Giampieri R; Maccaroni E; Del Prete M; Faloppi L; Bianconi M; Galizia E; Loretelli C; Belvederesi L; Bittoni A; Cascinu S
    Br J Cancer; 2012 Feb; 106(5):799-804. PubMed ID: 22315053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
    Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
    Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Correlation between TBARS levels and glycolytic enzymes: the importance to the initial evaluation of clinical outcome of colorectal cancer patients.
    Farias IL; Farias JG; Rossato L; Ara├║jo MC; Chiesa J; Morsh V; Schetinger MR
    Biomed Pharmacother; 2011 Sep; 65(6):395-400. PubMed ID: 21715128
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
    Weissenberger C; Von Plehn G; Otto F; Barke A; Momm F; Geissler M
    Anticancer Res; 2005; 25(3A):1787-93. PubMed ID: 16033101
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.